Literature DB >> 12036457

Stability of a recombinant adenoviral vector: optimization of conditions for storage, transport and delivery.

Hideyo Ugai1, Sanae Watanabe, Erika Suzuki, Hatsumi Tsutsui-Nakata, Kazunari K Yokoyama, Takehide Murata.   

Abstract

Recombinant viral vectors have been developed for use as therapeutic agents and for the introduction of exogenous genes into living cells. However, little is known about the viability and stability of such recombinant viruses during storage, transport and delivery under various conditions. We describe here an analysis of the stability of an adenoviral vector in crude solutions of cell lysates during freezing and thawing and during storage at various temperatures in the presence and in the absence of glycerol. For example, the titer of adenoviruses in crude lysates of infected cells was reduced only ten-fold or three-fold after two hundred rounds of freezing and thawing or after incubation at 28 degrees C for 14 days, respectively. Our observations indicate that recombinant adenoviral vector was more stable than expected both during freezing and thawing and during storage at low temperatures. Our results confirm the importance of appropriate conditions for the delivery and transport of recombinant adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036457      PMCID: PMC5927025          DOI: 10.1111/j.1349-7006.2002.tb01296.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

Review 1.  Prospects for fetal gene therapy.

Authors:  E Y Yang; A W Flake; N S Adzick
Journal:  Semin Perinatol       Date:  1999-12       Impact factor: 3.300

2.  Instability of adenoviral vectors during transport and its implication for clinical studies.

Authors:  C Nyberg-Hoffman; E Aguilar-Cordova
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

Review 3.  Human adenovirus vectors for gene transfer into mammalian cells.

Authors:  M M Hitt; C L Addison; F L Graham
Journal:  Adv Pharmacol       Date:  1997

4.  Sensitivity and reproducibility in adenoviral infectious titer determination.

Authors:  C Nyberg-Hoffman; P Shabram; W Li; D Giroux; E Aguilar-Cordova
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.

Authors:  Y Yoshida; H Hamada
Journal:  Biochem Biophys Res Commun       Date:  1997-01-13       Impact factor: 3.575

6.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

7.  Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase.

Authors:  Y Kanegae; G Lee; Y Sato; M Tanaka; M Nakai; T Sakaki; S Sugano; I Saito
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

8.  A simple and efficient method for purification of infectious recombinant adenovirus.

Authors:  Y Kanegae; M Makimura; I Saito
Journal:  Jpn J Med Sci Biol       Date:  1994-06

9.  Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions.

Authors:  M A Croyle; Q C Yu; J M Wilson
Journal:  Hum Gene Ther       Date:  2000-08-10       Impact factor: 5.695

Review 10.  Progress in the use of gene transfer methods to treat genetic blood diseases.

Authors:  D A Williams; F O Smith
Journal:  Hum Gene Ther       Date:  2000-10-10       Impact factor: 5.695

View more
  5 in total

1.  Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Authors:  Hideyo Ugai; Anton V Borovjagin; Long P Le; Minghui Wang; David T Curiel
Journal:  J Mol Biol       Date:  2006-12-06       Impact factor: 5.469

2.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

4.  ILDR2 has a negligible role in hepatic steatosis.

Authors:  Elizabeth J Millings; Maria Caterina De Rosa; Sarah Fleet; Kazuhisa Watanabe; Richard Rausch; Dieter Egli; Gen Li; Charles A Leduc; Yiying Zhang; Stuart G Fischer; Rudolph L Leibel
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

Review 5.  Adenoviruses as vaccine vectors.

Authors:  Nia Tatsis; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2004-10       Impact factor: 11.454

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.